Germany· DE-A57-db5805b6e4d5b31c
Palonosetron Beta
A palonosetron product containing palonosetron, registered in Germany by Betapharm Arzneimittel Gmbh. The same ATC class is registered in 18 of our 19 countries.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
Where it is registered
Palonosetron is registered in 18 of 19 countries.
Countries holding a registration under ATC A04AA05 (palonosetron), each read from that country’s own register.
- This record: Germany, from EMA Article 57 (European Union)
- 10 of them publish a price we can compare per daily dose
Palonosetron · ATC A04AA05
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of palonosetron costs, country by country.
Normalised to the WHO defined daily dose (0.5 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Palonosetron · price per daily dose (0.5 mg)
USD · FX 28 Sept 2026
- CH Switzerland$124.11
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Palonosetron
- Manufacturer
- Betapharm Arzneimittel Gmbh
- Country
- Germany (DE)
- ATC code
- A04AA05
- ATC class
- Palonosetron
- Defined daily dose
- 0.5 mg, O
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
490 interactions on record for palonosetron.
Graded by severity as the source publishes them — 139 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Palonosetron · interactions on record
490 records
- 139 severe
- 195 moderate
- 3 minor
- 153 info
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- FenfluramineA08AA02severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Palonosetron in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesPalonosetronBLuePoint Laboratories
- CzechiaALOXIHelsinn Birex Pharmaceuticals Ltd., Dublin
- FinlandAloxiParanova Oy
- BelgiumAkynzeo 235 mg - 0.25 mgHelsinn Birex Pharmaceuticals
- SwedenAloxi 250 mikrogram Injektionsvätska, lösningHelsinn Birex Pharmaceuticals Ltd
- SpainALOXI 250 microgramos SOLUCION INYECTABLEHelsinn Birex Pharmaceuticals Limited
- United KingdomAloxi 250micrograms/5ml solution for injection vialsChugai Pharma UK Ltd
- NetherlandsAloxi 0,25 mg/5 ml, oplossing voor injectieHelsinn Birex Pharmaceuticals Limited
Authorised across Europe · EMA
The same active substance is authorised in 28 EEA countries. Names it is sold under:
- Austria · Palonosetron Kalceks
- Belgium · Palonosetron Fresenius Kabi, Palonosetron Juta
- Bulgaria · Ферант
- Cyprus · Ferant, Injosetron
- Czechia · Ferant, Palonosetron Fresenius Kabi
- Denmark · Palonosetron Kalceks, Palonosetron Macure
- Estonia · Ferant, Palonosetron Kalceks
- Spain · Ferant, Palonosetrón Qilu
- Finland · Palonosetron Fresenius Kabi, Palonosetron Macure
- France · Palonosetron Kalceks, Palonosetron Reig Jofre
- United Kingdom (Northern Ireland) · Palonosetron Fresenius Kabi, Palonosetron Hydrochloride Qilu Pharma Spain
- Greece · Ferant, Injosetron
- Croatia · Ferant, Palonozetron Kalceks
- Hungary · Palonosetron Kalceks, Palonosetron Onkogen
- Ireland · Palonosetron
- Iceland · Aloxi, Palonosetron Accord
- Italy · Palonosetron Dr. Reddy’s, Palonosetron Fresenius Kabi
- Liechtenstein · Aloxi, Palonosetron Accord
- Lithuania · Ferant
- Latvia · Ferant, Palonosetron Kalceks
- Malta · Ferant, Palonosetron Anfarm
- Netherlands · Palonosetron Fresenius Kabi
- Norway · Aloxi, Palonosetron Accord
- Portugal · Ferant, Palanossetrom Fresenius Kabi
- Romania · Ferant, Palonosetron Dr. Reddy’s
- Sweden · Ferant, Palonosetron Fresenius Kabi
- Slovenia · Ferant, Palonosetron Fresenius Kabi
- Slovakia · Ferant, Palonosetron Fresenius Kabi
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f1131a5c-bf73-47d9-abc6-ae19b5093a60 GET /v1/drugs/f1131a5c-bf73-47d9-abc6-ae19b5093a60?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Intravenous Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Palonosetron",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about palonosetron.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.